In Brief: Ephedrine ban
This article was originally published in The Tan Sheet
Executive Summary
Ephedrine ban: Proposed by Nassua County Executive Thomas Gulotta for sales of herbal "stimulants" containing ephedrine. Announced on April 16, the proposed legislative action is being drafted and is expected to be forwarded to the legislature the week of April 22. Gulotta called for the sales ban in response to the March death of a 20-year-old county resident who allegedly consumed a large amount of an ephedrine-containing herbal product. On March 5, FDA's regional office in Orlando, Fla. sent a warning letter to Jacksonville Beach, Fla.-based Carribbean Connection regarding a false ad claim that the company's "Herbal Ecstasy" was "FDA-approved." Gulotta cited Herbal Ecstasy as one of the problematic herbal products currently available in "novelty stores, health stores, smoke shops and beauty salons"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning